| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 06, 2026 |
Neogenomics Inc.
NEO
|
BUY |
$28.00
Est. +46%
|
$19.13 | $20.15 |
Pending
|
$16.42
-14.2%
|
| Aug 17, 2026 |
Freenome, Inc.
FRNM
|
BUY |
$17.00
Est. +47%
|
$11.56 | $16.62 |
Precision Hit (±3%)
|
$12.57
+8.7%
|
| Aug 05, 2026 |
SOPHiA Genetics SA
SOPH
|
BUY |
$9.00
Est. +32%
|
$6.84 | $8.98 |
Bullseye Hit (±1%)
|
$6.49
-5.1%
|
| Jul 31, 2026 |
Guardant Health Inc
GH
|
BUY |
$195.00
Est. +28%
|
$152.35 | $191.01 |
Precision Hit (±3%)
|
$157.88
+3.6%
|
| Jul 30, 2026 |
Adaptive Biotechnologies Corp
ADPT
|
BUY |
$25.00
Est. +11%
|
$22.56 | $30.75 |
Target Met
|
$23.95
+6.2%
|
| May 26, 2026 |
Guardant Health Inc
GH
|
BUY |
$155.00
Est. +30%
|
$118.95 | $191.01 |
Target Met
|
$157.88
+32.7%
|
| May 11, 2026 |
Personalis Inc
PSNL
|
BUY |
$11.00
Est. +84%
|
$5.98 | $17.64 |
Target Met
|
$15.88
+165.6%
|
| May 08, 2026 |
Cai International Inc
CAI
|
BUY |
$32.00
Est. +61%
|
$19.84 | $32.88 |
Precision Hit (±3%)
|
$30.71
+54.8%
|
| Mar 10, 2026 |
Exagen Inc
XGN
|
BUY |
$9.00
Est. +177%
|
$3.25 | $9.21 |
Precision Hit (±3%)
|
$7.43
+128.6%
|
| Mar 05, 2026 |
BillionToOne, Inc.
BLLN
|
BUY |
$140.00
Est. +93%
|
$72.66 | $150.44 |
Target Met
|
$101.03
+39.0%
|
| Mar 03, 2026 |
SOPHiA Genetics SA
SOPH
|
BUY |
$7.00
Est. +71%
|
$4.10 | $8.98 |
Target Met
|
$6.49
+58.3%
|
| Feb 26, 2026 |
Zoetis Inc - Ordinary Shares - Class A
ZTS
|
BUY |
$160.00
Est. +24%
|
$128.95 | $132.30 |
Pending
|
$79.59
-38.3%
|
| Feb 24, 2026 |
GeneDx Holdings Corp - Ordinary Shares - Class A
WGS
|
BUY |
$170.00
Est. +95%
|
$87.08 | $105.16 |
Pending
|
$66.29
-23.9%
|
| Feb 17, 2026 |
Exagen Inc
XGN
|
BUY |
$10.00
Est. +205%
|
$3.28 | $9.21 |
Pending
|
$7.43
+126.5%
|
| Dec 12, 2025 |
Castle Biosciences Inc
CSTL
|
BUY |
$50.00
Est. +32%
|
$37.97 | $44.28 |
Pending
|
$32.17
-15.3%
|
| Dec 01, 2025 |
BillionToOne, Inc.
BLLN
|
BUY |
$160.00
Est. +23%
|
$130.18 | $150.44 |
Pending
|
$101.03
-22.4%
|
| Nov 25, 2025 |
Tempus AI Inc. - Ordinary Shares - Class A
TEM
|
BUY |
$105.00
Est. +38%
|
$76.06 | $89.09 |
Pending
|
$64.34
-15.4%
|
| Nov 04, 2025 |
Exact Sciences Corp.
EXAS
|
BUY |
$85.00
Est. +27%
|
$66.98 | $104.98 |
Target Met
|
$104.91
+56.6%
|
| Oct 30, 2025 |
Guardant Health Inc
GH
|
BUY |
$100.00
Est. +5%
|
$95.55 | $191.01 |
Target Met
|
$157.88
+65.2%
|
| Sep 25, 2025 |
Guardant Health Inc
GH
|
BUY |
$80.00
Est. +32%
|
$60.75 | $183.42 |
Target Met
|
$157.88
+159.9%
|
| Aug 13, 2025 |
Cai International Inc
CAI
|
BUY |
$45.00
Est. +29%
|
$34.78 | $42.50 |
Miss
|
$30.71
-11.7%
|
| Aug 08, 2025 |
Tempus AI Inc. - Ordinary Shares - Class A
TEM
|
BUY |
$60.00
Est. +2%
|
$58.74 | $104.32 |
Target Met
|
$64.34
+9.5%
|
| Aug 06, 2025 |
Personalis Inc
PSNL
|
BUY |
$6.00
Est. +36%
|
$4.41 | $16.39 |
Target Met
|
$15.88
+260.1%
|
| Mar 12, 2025 |
MaxCyte Inc
MXCT
|
BUY |
$6.00
Est. +73%
|
$3.47 | $3.32 |
Miss
|
$1.30
-62.5%
|
| Jan 11, 2025 |
Neogenomics Inc.
NEO
|
BUY |
$18.00
Est. +22%
|
$14.77 | $16.18 |
Miss
|
$16.42
+11.2%
|
| Nov 12, 2024 |
Exagen Inc
XGN
|
BUY |
$5.00
Est. +79%
|
$2.79 | $12.23 |
Target Met
|
$7.43
+166.3%
|
| Nov 06, 2024 |
Exact Sciences Corp.
EXAS
|
SELL |
$65.00
Est. +10%
|
$72.42 | $38.81 (Low) |
Target Met
|
$104.91
-44.9%
|
| Sep 16, 2024 |
Exact Sciences Corp.
EXAS
|
BUY |
$82.00
Est. +18%
|
$69.48 | $72.82 |
Miss
|
$104.91
+51.0%
|
| Aug 23, 2024 |
Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A
DNA
|
SELL |
$7.00
Est. +16%
|
$8.30 | $5.01 (Low) |
Target Met
|
$10.07
-21.3%
|
| Aug 19, 2024 |
Caredx Inc
CDNA
|
BUY |
$40.00
Est. +21%
|
$33.00 | $34.84 |
Miss
|
$67.08
+103.3%
|
| Aug 16, 2024 |
Personalis Inc
PSNL
|
BUY |
$7.00
Est. +17%
|
$5.99 | $7.79 |
Target Met
|
$15.88
+165.1%
|
| Aug 08, 2024 |
Personalis Inc
PSNL
|
BUY |
$5.50
Est. +60%
|
$3.43 | $7.79 |
Target Met
|
$15.88
+363.0%
|
| Jul 31, 2024 |
GeneDx Holdings Corp - Ordinary Shares - Class A
WGS
|
BUY |
$45.00
Est. +49%
|
$30.13 | $116.20 |
Target Met
|
$66.29
+120.0%
|
| Jul 29, 2024 |
Guardant Health Inc
GH
|
BUY |
$50.00
Est. +42%
|
$35.28 | $53.42 |
Target Met
|
$157.88
+347.5%
|
| Jun 26, 2024 |
Exact Sciences Corp.
EXAS
|
BUY |
$70.00
Est. +69%
|
$41.37 | $72.82 |
Target Met
|
$104.91
+153.6%
|
| Jun 26, 2024 |
GeneDx Holdings Corp - Ordinary Shares - Class A
WGS
|
BUY |
$35.00
Est. +34%
|
$26.19 | $116.20 |
Target Met
|
$66.29
+153.1%
|
| May 23, 2024 |
Guardant Health Inc
GH
|
BUY |
$45.00
Est. +100%
|
$22.51 | $52.92 |
Target Met
|
$157.88
+601.4%
|
| May 16, 2024 |
Bionano Genomics Inc
BNGO
|
BUY |
$2.00
Est. +74%
|
$1.15 | $70.80 |
Target Met
|
$1.22
+6.1%
|
| May 16, 2024 |
Renalytix Plc - ADR
RNLX
|
BUY |
$2.00
Est. +251%
|
$0.57 | $0.50 |
Miss
|
$0.21
-63.7%
|
| May 14, 2024 |
Akoya Biosciences Inc
AKYA
|
BUY |
$6.00
Est. +46%
|
$4.12 | $3.42 |
Miss
|
$1.29
-68.7%
|
| May 13, 2024 |
Natera Inc
NTRA
|
BUY |
$125.00
Est. +19%
|
$105.29 | $183.00 |
Target Met
|
$399.42
+279.4%
|
| May 02, 2024 |
Neogenomics Inc.
NEO
|
BUY |
$21.00
Est. +50%
|
$13.96 | $19.12 |
Miss
|
$16.42
+17.6%
|
| Apr 30, 2024 |
GeneDx Holdings Corp - Ordinary Shares - Class A
WGS
|
BUY |
$19.00
Est. +73%
|
$11.00 | $116.20 |
Target Met
|
$66.29
+502.6%
|
| Apr 08, 2024 |
Lucid Diagnostics Inc
LUCD
|
BUY |
$2.50
Est. +169%
|
$0.93 | $1.80 |
Miss
|
$0.38
-59.4%
|
| Apr 04, 2024 |
Adaptive Biotechnologies Corp
ADPT
|
BUY |
$5.00
Est. +87%
|
$2.68 | $36.04 |
Target Met
|
$23.95
+793.7%
|
| Mar 13, 2024 |
MaxCyte Inc
MXCT
|
BUY |
$8.00
Est. +92%
|
$4.16 | $5.20 |
Miss
|
$1.30
-68.8%
|
| Jan 03, 2023 |
SOPHiA Genetics SA
SOPH
|
BUY |
$6.00
Est. +191%
|
$2.06 | - | - |
$6.49
+215.0%
|
| Aug 26, 2022 |
MDxHealth SA
MDXH
|
BUY |
$15.00
Est. +83%
|
$8.19 | - | - |
$0.18
-97.8%
|
| Aug 14, 2022 |
MaxCyte Inc
MXCT
|
BUY |
$11.00
Est. +87%
|
$5.87 | - | - |
$1.30
-77.9%
|
| Jul 01, 2022 |
Renalytix Plc - ADR
RNLX
|
BUY |
$5.00
Est. +104%
|
$2.45 | - | - |
$0.21
-91.5%
|